Pfizer

۱ مطلب

  • Pfizer Inc and Johnson & Johnson said they were scrapping further studies of one of the most anticipated experimental Alzheimers disease treatments after the drug failed to help patients with the memory - robbing condition in a second high - profile late stage clinical trial.